6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide,
EX 527,
EX-527,
EX527 cpd,
selisistat,
SEN0014196,
49843-98-3,
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide,
Selisistat,
EX-527,
EX 527,
SEN0014196,
EX527,
SIRT1 Inhibitor III,
EX 527 (Selisistat),
CHEMBL420311,
CHEBI:90369,
AK162085,
EX-527 S-enantiomer,
1H-Carbazole-1-carboxamide, 6-chloro-2,3,4,9-tetrahydro-,
6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide, racemic,
Selisistat [INN],
EX 527 (SEN0014196),
6-chloro-1,2,3,4,9-pentahydro-4aH-carbazolecarboxamide,
SEN-0014196,
EX-527(Selisistat),
AC1NOH0T,
Selisistat (EX 527),
Cambridge id 6859180,
Oprea1_353257,
Oprea1_367943,
MLS006011757,
GTPL8100,
SCHEMBL1275557,
CTK8F9709,
AOB2079,
QCR-195,
FUZYTVDVLBBXDL-UHFFFAOYSA-N,
HMS3654P22,
rac-6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide,
BCP02889,
EX-A1064,
KS-00000FE8,
ABP000688,
BDBM50178769,
BN0883,
MFCD03009471,
s1541,
SBB014468,
STK522511,
AKOS002364303,
BCP9000673,
CCG-208710,
CS-0960,
EX 527/,
MCULE-2491423827,
SB16664,
EX 527,SEN0014196,
NCGC00242458-01,
BC623031,
HY-15452,
SC-93906,
SMR004703473,
ST082785,
BCP0726000108,
AB0033787,
AX8108686,
DB-082965,
EX-527, >=98% (HPLC),
FT-0698480,
ST24045255,
SW218147-2,
X7534,
A21392,
F10031,
S-7754,
AB00121519-01,
SR-01000501008,
SR-01000501008-1,
BRD-A73908300-001-04-2,
EX 527, EX527, 49843-98-3,
(+/-)-6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide,
6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxylic acid, amide,
EX-527 R-enantiomer,
EX527 cpd,
D0E3LP,
UNII-L19ECD5014,
C13H13ClN2O,
SEN-196,
L19ECD5014,
ZINC00093989,
CID5113032,
C2739,
C550547,
SIRT1 inhibitors (Huntingtons disease), Elixir/Siena,
6-Chloro-2,3,4,9-tetrahydro-1H-carbazol-1-ylformamide,
848193-68-0,
Sirtuin-1 inhibitors (oral, Huntington's disease), Elixir/Siena,
848193-69-1,